CLIA certification is the federal standard that determines whether a genetic lab can produce results a qualified healthcare provider can actually act on. The Precision Peptide Genetic Test uses Illumina Global Screening Array genotyping at CLIA-certified labs — processing 57 SNPs across 48 genes for 150+ genetic insights. This post explains what CLIA certification requires and why the standard matters.

The Precision Peptide Genetic Test analyzes your genetic response to the pathways targeted by 49 unique compounds across five protocol families — GLP-1, growth hormone, androgens, estrogens, and vascular modulators. This post breaks down how each protocol family maps to genetic pathways, what the 49-peptide panel covers, and what your results reveal.

Genetic testing reveals tendencies, not outcomes — a FOXO3 variant doesn't predict lifespan, a slow-COMT variant doesn't diagnose any condition, an ACTN3 XX genotype doesn't cap muscle growth. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150+ genetic insights. Understanding what DNA can and cannot tell you is the difference between informed and overconfident.

Your Precision Peptide Genetic Test report delivers 150+ insights across 14 pathways — FOXO3 for longevity, ACTN3 for muscle, COMT for methylation, and more. This guide walks through how to read pathway scores, interpret gene variants, and synthesize findings into the informed conversation every peptide protocol decision should start with.

Before committing to a peptide protocol, genetic testing reveals how your body will actually respond across GLP-1 signaling, growth hormone axis, estrogen clearance, and sexual response pathways. The Precision Peptide Genetic Test maps 14 pathways, 49 peptides, and 150+ genetic insights. Test first. Invest second. That sequence is the entire premise of precision peptide decisions.

The precision health stack is a 4-layer system: genetic testing as the foundation, blood work for state data, supplements and lifestyle for baseline support, and protocols as the intervention layer. The Precision Peptide Genetic Test anchors the stack — analyzing 14 pathways, 49 peptides, and 150+ genetic insights that shape how every layer above performs.

Genetic peptide testing analyzes how your DNA shapes 14 biological pathways that peptide protocols target — from GLP-1 signaling to growth hormone axis to estrogen clearance. The PlexusDx Precision Peptide Genetic Test delivers 150+ insights across 49 unique peptides, turning peptide decisions from guesswork into evidence-based conversations with your healthcare provider.

The Precision Peptide Genetic Test processes raw DNA through Illumina Global Screening Array genotyping, CLIA-certified lab analysis, and AI-driven pathway interpretation — transforming 57 SNPs across 48 genes into 150+ actionable insights spanning 14 pathways and 49 peptides. This post explains how that pipeline works end to end, from saliva sample to personalized genetic report.

The PlexusDx Precision Peptide Genetic Test analyzes 17 longevity-aging genetic insights across five peptide pathways — Epitalon, FOXO4-DRI, Glutathione, Humanin, and Vilon — covering 15 SNPs across 14 genes including FOXO3, TERT, SIRT1, GPX1, and PPARGC1A. This article explains what each insight reveals and why peptide-specific longevity testing is a distinct category of genetic analysis.

The PlexusDx Precision Peptide Genetic Test analyzes 34 weight management genetic insights — covering 8 peptide pathways, 11 SNPs, and 9 genes including FTO, MC4R, PPARG, TCF7L2, and GIPR. This comprehensive guide explains what each insight cluster covers, which peptide pathways are analyzed, and why genetic specificity is the missing variable in most weight management decisions.

In April 2026, a Nature GWAS of 27,885 GLP-1 medication users found GIPR rs1800437 associated with outcomes specifically in tirzepatide users — not in GLP-1-only agonist users. This article explains what that finding means, why the dual-receptor distinction matters, and why the PlexusDx Precision Peptide Genetic Test directly genotypes this SNP across 34 weight management insights.

The PlexusDx Precision Peptide Genetic Test analyzes 34 weight management genetic insights — including the pathways most relevant to GLP-1 receptor signaling. This article explains what the research shows about genetics and semaglutide response, why MTHFR methylation status matters in the broader metabolic picture, and how genetic testing can help inform a smarter weight management approach.

The PlexusDx Precision Peptide Genetic Test analyzes 34 weight management genetic insights — including GLP-1 receptor signaling and GIPR response pathways. This article explains how genes like FTO, MC4R, and PPARG influence appetite, fat metabolism, and weight regulation, and why your DNA may be the most underused variable in any weight management decision.

A Diabetes Care analysis estimates tirzepatide may reduce MACE risk by up to 28% and all-cause mortality by 39% compared to theoretical placebo — a figure the SURPASS-CVOT trial design couldn't directly show. Here's what the imputed placebo data reveals, and why GLP-1 receptor pathway genetics matter before any weight management decision.

Your capacity for muscle growth, fiber composition, and anabolic signaling efficiency are substantially inherited — shaped by variants in IGF1, MSTN, ACTN3, and GHSR before your first training session. The PlexusDx Precision Peptide Genetic Test analyzes 15 Muscle Growth genetic insights as part of 14 peptide-related biological pathways, 49 unique peptides, and 150 total genetic insights.

Your emotional regulation, stress resilience, and social bonding biology are partly inherited — shaped by variants in OXTR, DRD2, SLC6A4, and COMT before your first experience of the world. The PlexusDx Precision Peptide Genetic Test analyzes 8 Mood genetic insights as part of 14 peptide-related biological pathways, 49 unique peptides, and 150 total genetic insights.

Your skin's collagen density, antioxidant defense capacity, and barrier integrity are shaped as much by your inherited genetics as by your skincare routine. The PlexusDx Precision Peptide Genetic Test analyzes 14 Skin Health genetic insights — the third-largest pathway in a panel spanning 14 peptide-related biological pathways, 49 unique peptides, and 150 total genetic insights.

Your sleep biology is not just a habit — it is partly inherited. The CLOCK gene governs your circadian timing system, and the ADA gene shapes adenosine-driven sleep pressure. The PlexusDx Precision Peptide Genetic Test analyzes 3 Sleep genetic insights as part of 14 peptide-related biological pathways, 49 unique peptides, and 150 total genetic insights.

FOXO3 is the most replicated longevity gene in human genetics research — and it is one of 17 genetic insights in the PlexusDx Longevity & Aging pathway. The Precision Peptide Genetic Test maps your inherited cellular aging biology across telomere maintenance, stress resistance signaling, and mTOR/SIRT1 activity — part of 14 peptide-related biological pathways and 150 total genetic insights.

GLP-1 receptor signaling is one of the most genetically variable biological systems governing weight management — shaping appetite regulation, glucose metabolism, and satiety response at the DNA level. The PlexusDx Precision Peptide Genetic Test analyzes 33 Weight Management genetic insights, the largest pathway in a panel spanning 14 peptide-related biological pathways, 49 unique peptides, and 150 total genetic insights.

Your genes influence more than how fast you heal — they shape the biological architecture of tissue repair itself. The PlexusDx Precision Peptide Genetic Test analyzes 9 Tissue Repair genetic insights across 14 peptide-related biological pathways, covering the genetic variants that govern growth hormone signaling, collagen synthesis, and cellular repair mechanisms at the DNA level.

The BDNF Val66Met variant (rs6265) is one of the most studied cognitive gene variants — shaping brain-derived neurotrophic factor secretion, neuroplasticity, and memory function. The PlexusDx Precision Peptide Genetic Test analyzes BDNF as part of 6 Cognition genetic insights across 14 peptide-related biological pathways and 150 total genetic insights.

If your GLP-1 medication isn't delivering expected results, genetics may be the variable no one has asked about yet. A 2025 Cleveland Clinic study found certain genetic profiles made people up to 50% more likely not to lose weight on GLP-1 medications. The PlexusDx Peptide Pathways Report delivers 33 weight management insights — across semaglutide, tirzepatide, and six more peptides — to give you that answer before months of trial and error.

Generic GLP-1 diet advice ignores the variable most likely to explain your results: your genetics. The PlexusDx Peptide Pathways Report delivers 33 genetic insights in the weight management pathway alone — covering semaglutide, tirzepatide, and six more peptides across FTO, TCF7L2, MC4R, PPARG, ADIPOQ, and LEPR. Your protocol deserves a diet plan built on your DNA, not the population's.

Standard peptide protocols are built on population averages — your genetics aren't average. The PlexusDx Peptide Pathways Report delivers 150 genetic insights across 14 health pathways and 49 peptides, mapping your specific DNA variants to the compounds most studied in the context of your biology. Population averages are a starting point. Your genetics are the upgrade.

Most peptide protocols skip the most important variable: your genetics. The PlexusDx Precision Peptide Genetic Test analyzes 150 genetic insights across 14 health pathways and 49 peptides — giving you and your healthcare provider a precision foundation before any protocol decision is made. Your DNA never changes. The insights it holds shouldn't go unmeasured.

Your methylation blood test measures three biomarkers — homocysteine, folate, and B12. Here's what each one means, what your results tell you, and how blood testing connects to genetic methylation testing.